收费全文 | 17398篇 |
免费 | 1113篇 |
国内免费 | 377篇 |
耳鼻咽喉 | 179篇 |
儿科学 | 84篇 |
妇产科学 | 198篇 |
基础医学 | 674篇 |
口腔科学 | 409篇 |
临床医学 | 1928篇 |
内科学 | 832篇 |
皮肤病学 | 92篇 |
神经病学 | 483篇 |
特种医学 | 465篇 |
外国民族医学 | 2篇 |
外科学 | 4883篇 |
综合类 | 4311篇 |
预防医学 | 930篇 |
眼科学 | 342篇 |
药学 | 1904篇 |
46篇 | |
中国医学 | 329篇 |
肿瘤学 | 797篇 |
2024年 | 34篇 |
2023年 | 265篇 |
2022年 | 470篇 |
2021年 | 610篇 |
2020年 | 621篇 |
2019年 | 518篇 |
2018年 | 515篇 |
2017年 | 567篇 |
2016年 | 595篇 |
2015年 | 619篇 |
2014年 | 1322篇 |
2013年 | 1092篇 |
2012年 | 1172篇 |
2011年 | 1266篇 |
2010年 | 1053篇 |
2009年 | 972篇 |
2008年 | 876篇 |
2007年 | 907篇 |
2006年 | 814篇 |
2005年 | 746篇 |
2004年 | 468篇 |
2003年 | 415篇 |
2002年 | 394篇 |
2001年 | 338篇 |
2000年 | 254篇 |
1999年 | 224篇 |
1998年 | 198篇 |
1997年 | 193篇 |
1996年 | 151篇 |
1995年 | 146篇 |
1994年 | 117篇 |
1993年 | 106篇 |
1992年 | 84篇 |
1991年 | 102篇 |
1990年 | 86篇 |
1989年 | 72篇 |
1988年 | 68篇 |
1987年 | 83篇 |
1986年 | 61篇 |
1985年 | 63篇 |
1984年 | 49篇 |
1983年 | 29篇 |
1982年 | 24篇 |
1981年 | 25篇 |
1980年 | 30篇 |
1979年 | 15篇 |
1978年 | 9篇 |
1977年 | 13篇 |
1974年 | 11篇 |
1973年 | 6篇 |
: Two thousand six hundred sixty-seven PSA values from 400 patients treated with radiotherapy for localized adenocarcinoma of the prostate were analyzed with respect to PSA patterns and clinical outcome. Patients had received no hormonal therapy or prostate surgey and had ?4 PSA values post-treatment PSA rate of rise, determined by the slope of the natural log, was classified as gradual (< 0.69 log (ng/ml)/year, or doubling time (DT) > 1 year), moderate (0.69-1.4 log (ng/ml)/year, or DT 6 months-1 year), or rapid [>1.4 log (ng/ml)/year, or DT < 6 months].
: SIxty-one percent of patients had non-rising PSA following treatment; 25% of patients with rising PSA developed clinical failure, and 93% of patients with clinical failure had rising PSA. The rate of rise discerned different clinical failure patterns. Local failure occurred in 23% of patients with moderate rate of rise versus 7% with gradual rise (p = 0.0001). Metastatic disease developed in 46% of those with rapid versus 8% with moderate rise (p < 0.0001). By multivariate analysis, in addition to rate of rise, PSA nadir and rate of decline predicted local failure; those with post-treatment nadir of 1–4 ng/ml were five times more likely to experience local failure than nadir < 1 ng/ml (p = 0.0002). Rapid rate of rise was the most significant independent predictor of metastastic failure.
: The rate of PSA rise following definitive radiotherapy can predict clinical failure patterns, with a rapidly rising PSA indicating metastatic recurrence and moderately rising PSA local recurrence. This information could potentially dirent therapy; if the rise predicts metastatic failure hormonal therapy could be cosidereed, while aggressive salvage therapy may benefit subclinical local recurrence identified by a moderate rate of PSA rise. 相似文献
Methods: We administered
Results: SUV immediately diffused from the lumbar site of injection to the head and were cleared between 1 and 24 h after injection. MLV were cleared more slowly from the spinal space and appeared in the head region 1 h after injection where they accumulated up to 24 h. These differences were explained in terms of vesicle sizes and volumes. SUV with 0.05 μm diameters were rapidly absorbed into the blood through the arachnoid granulations. In contrast, particles larger than the upper size limit of the arachnoid granulations permeability (±8 μm) could accumulate in the head with a slow elimination rate.
Conclusion: This difference in clearance from the intrathecal space outlines the importance of defining the size of the liposomes, the distribution of a tracer or a drug inside the liposomal preparation, the chemical stability and the absence of toxic degradation products of liposome formulations before clinical use. 相似文献